SCHEMBL19851099

SCHEMBL19851099

CCOC(=O)CSc1nc2cccnc2n1-c1c(C)cc(C)cc1C

nearest known ligand 0.68

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.68
LMNA P02545 3/20 0.68
ALOX15 P16050 1/20 0.55
KDM4E B2RXH2 3/20 0.54
ALDH1A1 P00352 7/20 0.52
MEN1 O00255 1/20 0.52
RECQL P46063 1/20 0.52
KMT2A Q03164 1/20 0.52
MAPK1 P28482 4/20 0.51
MAPT P10636 2/20 0.51
SMN1; SMN2 Q16637 4/20 0.50
ATM Q13315 1/20 0.50
PSMD14 O00487 1/20 0.50
GAA P10253 1/20 0.50
PDE10A Q9Y233 1/20 0.48
TP53 P04637 1/20 0.47
HPGD P15428 1/20 0.47
HTT P42858 1/20 0.47
HSD17B10 Q99714 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19851021 0.88 TSHR (0.54) TSHRLMNAALOX15KDM4EALDH1A1
SCHEMBL19851019 0.87 ALDH1A1 (0.51) TSHRLMNAALOX15ALDH1A1MEN1
SCHEMBL19851025 0.83 TSHR (0.50) TSHRLMNAALOX15KDM4EALDH1A1
SCHEMBL21093721 0.83 TSHR (0.47) TSHRLMNAALDH1A1MEN1RECQL
SCHEMBL19851010 0.82 LMNA (0.47) TSHRLMNAALOX15KDM4EALDH1A1
SCHEMBL19851100 0.80 TSHR (0.66) TSHRLMNAALOX15KDM4EALDH1A1
SCHEMBL19851028 0.79 TSHR (0.42) TSHRLMNAALDH1A1MEN1RECQL
SCHEMBL19851011 0.79 MAPT (0.45) TSHRLMNAALDH1A1MEN1RECQL
SCHEMBL21093468 0.78 TSHR (0.42) TSHRLMNAALOX15ALDH1A1MEN1
SCHEMBL19851013 0.75 SLC22A12 (0.50) TSHRLMNAALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3495362-B1 IMIDAZOPYRIDINE THIOGLYCOLIC ACID DERIVATIVE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF UNIV SHANDONG (CN) 2021-10-27 EP disclosed
US-10399978-B2 Imidazopyridine thioglycolic acid derivatives as potent inhibitors of human urate transporter 1 SHANDONG UNIVERSITY (CN) 2019-09-03 US disclosed
US-20190225606-A1 Novel Imidazopyridine Thioglycolic Acid Derivatives as Potent Inhibitors of Human Urate Transporter 1 SHANDONG UNIVERSITY (CN) 2019-07-25 US disclosed
EP-3495362-A1 IMIDAZOPYRIDINE THIOGLYCOLIC ACID DERIVATIVE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF Shandong University (CN) 2019-06-12 EP disclosed
WO-2018023851-A1 IMIDAZOPYRIDINE THIOGLYCOLIC ACID DERIVATIVE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF 山东大学 2018-02-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190225606-A1 Novel Imidazopyridine Thioglycolic Acid Derivatives as Potent Inhibitors of Human Urate Transporter 1 SLC29A1, SLC28A1, SLC5A1 TSHR 2731/4885LMNA 4231/4885ALOX15 3691/4885
US-10399978-B2 Imidazopyridine thioglycolic acid derivatives as potent inhibitors of human urate transporter 1 SLC29A1, SLC28A1, SLC5A1 TSHR 2444/4885LMNA 3991/4885ALOX15 3564/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.